This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A . Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997; 155: 105–117.
Phillips JH, Gumperz JE, Parham P, Lanier LL . Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995; 268: 403–405.
Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci USA 1998; 95: 1172–1177.
Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795–799.
Tanaka J, Toubai T, Tsutsumi Y, Miura Y, Kato N, Shintarou Umehara et al. Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 2004; 104: 768–774.
Raulet DH . Roles of the NKG2D immunoreceptor and its ligands. Nature Rev 2003; 3: 781–790.
Farag SS, George SL, Lee EJ, Baer M, Dodge RK, Becknell B et al. Postremission Therapy with Low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: cancer and leukemia Group B Study 9420. Clin Cancer Res 2002; 8: 2812–2819.
Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 2003; 102: 1389–1396.
Wang J, Springer TA . Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol Rev 1998; 163: 197–215.
Groh V, Wu J, Yee C, Spies T . Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419: 734–738.
Acknowledgements
We thank Ms M Mayanagi for her technical assistance. This work was supported in part by a grant from the Idiopathic Hematological Disease and Bone Marrow Transplantation Research Committee of the Ministry of Health and Welfare of Japan and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan and by grants from Kirin Brewery Company, Chugai Pharmaceutical Company and Kyowa Hakko Pharmaceutical Company (Tokyo, Japan).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tanaka, J., Iwao, N., Toubai, T. et al. Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. Leukemia 19, 486–489 (2005). https://doi.org/10.1038/sj.leu.2403611
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403611
This article is cited by
-
Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells
Annals of Hematology (2010)
-
Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells
Leukemia (2007)